Enuresis Alarm - Is a Manual Trigger System Beneficial?

NCT ID: NCT03522818

Last Updated: 2021-04-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-09

Study Completion Date

2023-09-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate whether the bedwetting alarm trigger activated by parents to wake their child, in addition to the moisture alarm, will improve treatment success compared to the moisture alarm alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Nocturnal enuresis is a common issue in children, and use of bedwetting alarms has shown the best long-term success. However, use of alarms is very time-intensive, often taking months before yielding results. Researchers in the division of pediatric urology are initiating a randomized controlled study comparing a standard bedwetting alarm with a newly developed technology, with the hope that the new alarm will result in better, more rapid, and easier treatment for bedwetting.

Children between the ages of 5 to 15 years old who have issues with bedwetting after successful toilet training may qualify for the study.

Participants must first be evaluated by a pediatric urology specialist.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Enuresis, Nocturnal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal

Group will use the alarm as provided by the manufacture.

Group Type ACTIVE_COMPARATOR

Normal

Intervention Type BEHAVIORAL

Will use the alarm as provided by the manufacture.

Manual trigger

Group will use the same model but will be instructed to manually trigger the alarm 1-2 hours after the child falls asleep.

Group Type EXPERIMENTAL

Manual Trigger

Intervention Type BEHAVIORAL

Will use the alarm as provided by the manufacture but parent has to manual trigger the alarm 1-2 hours after the child falls asleep.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Manual Trigger

Will use the alarm as provided by the manufacture but parent has to manual trigger the alarm 1-2 hours after the child falls asleep.

Intervention Type BEHAVIORAL

Normal

Will use the alarm as provided by the manufacture.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* children ages 5-15 years
* Diagnosis of Primary Monosymptomatic Nocturnal Enuresis
* \>2 wet nights per week
* Score of 7 or below on questions 1-6 and 9-13 on Vancouver Dysfunctional Elimination Questionnaire
* Patients/parents compliance in recording data \> 50% of nights

Exclusion Criteria

* Known comorbid conditions: daytime incontinence, anatomic abnormalities (hydronephrosis, VUR), recurrent urinary tract infection, dysuria, neurogenic bladder, developmental delay, encopresis, diabetes insipidus, previous history of urologic surgery
* Concomitant DDAVP use, anticholinergic use, B3 agonist use
Minimum Eligible Age

5 Years

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

PottyMD

UNKNOWN

Sponsor Role collaborator

Gina Lockwood

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gina Lockwood

Principal Investigator, Medical Doctor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gina M Lockwood, MD, MS

Role: PRINCIPAL_INVESTIGATOR

University of Iowa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Iowa

Iowa City, Iowa, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gina M Lockwood, MD, MS

Role: CONTACT

(319) 353-8673

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gina Lockwood, MD, MS

Role: primary

319-353-8673

Denise Juhr, BS

Role: backup

(319) 356-1111 ext. Juhr

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201801703

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Teaching Injury Prevention
NCT01958099 COMPLETED NA